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Abstract In this study we have investigated the suitability 
of a number of different mesoporous silica nanoparticle 
structures for carrying a drug cargo. We have fully 
characterized the nanoparticles in terms of their physical 
parameters; size, surface area, internal pore size and 
structure. These data are all required if we are to make an 
informed judgement on the suitability of the structure for 
drug delivery in vivo. With these parameters in mind, we 
investigated the loading/ unloading profile of a model 
therapeutic into the pore structure of the nanoparticles. 
We demonstrate that the release can be controlled by 
capping the pores on the nanoparticles to achieve 
temporal control of the unloading. We have also 
examined the rate and mechanism of the degradation of 
the nanoparticles over an extended period of time. The 
eventual dissolution of the nanoparticles after cargo 
release is a desirable property for a drug delivery system.     
 






Mesoporous silica nanoparticles (MSNPs) are receiving 
increasing interest from the scientific community for their 
potential as drug delivery systems both in vitro and in
vivo (see [1], references 1–17). MSNPs typically have 
particle diameters in the 50-300 nm range and narrow 
pore size distributions of the order 2-6 nm. Their 
structure and morphology are controllable at both the 
nanometre and micrometre scale, yielding high surface 
area and pore volumes of the MSNPs and enabling a high 
cargo carrying capacity. (For an excellent review of the 
synthesis methods of MSNPS see [2]). The silica surface 
has a high density of silanol groups which can be 
modified with a wide range of organic functional groups 
[3], allowing for modification with targeting agents such 
as peptides, antibodies or folic acid, or biocompatible 
polymers such as polyethylene glycol (PEG) to minimize 
opsonization which would lead to the rapid clearance of 
the nanoparticles [4]. In addition, the ability of silica to 
decompose into relatively harmless silicic acid by-
products presents fewer challenges for long-term use 
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than, for example, carbon nanotubes or gold nanoparticles 
which are not metabolized [5]. 
 
The capacity of MSNPs to carry cargo has been 
demonstrated with a number of different drugs, 
including ibuprofen [6-9], diflunisal [10], naproxen [10], 
captopril [11], aspirin [12], gentamycin [13], erythromycin 
[14], and amoxicillin [15]. The internalization of the cargo 
is important since new drugs are often insoluble in water, 
and it has been estimated that around 95 % of all new 
potential therapeutics have poor pharmacokinetics and 
biopharmaceutical properties [16].  
 
In terms of drug delivery, the external diameter of the 
nanoparticles is of particular importance for drug delivery. 
The circulation of nanoparticles and their uptake by 
different tissues varies widely, and uptake by diseased 
tissue differs from healthy tissue. The tight junctions of the 
blood-brain-barrier only permit the passage of particles 
below 1 nm whereas continuous capillaries such as those 
found in the muscles, skin and lungs are permeable by up 
to approximately 6 nm. Larger particles of up to 50-60 nm 
are able to exit the fenestrated capillaries of the kidney, 
intestine, and some endocrine/exocrine glands. The 
largest particles, of up to 600 nm, will be able to 
accumulate in the liver, spleen and bone marrow [17]. 
However, it has been shown that the bio-distribution of 
nanoparticles is altered in animal models bearing tumours 
compared to control animals. The microvasculature 
surrounding tumours is highly permeable and leaky, and 
tumours have less efficient efflux mechanisms (the EPR 
effect) which will influence the overall bio-distribution. 
This means that nanoparticles of the right size will likely 
passively accumulate at the tumour site. 
 
At the cellular level, particle internalization is also 
dependent on the size, shape and surface chemistry of the 
nanoparticles. Small particles are internalized by 
endocytosis [18], and the uptake rate depends on the 
competition between the bending energy and stretching 
energy of the membrane which is related to both its size 
and shape [19]. Generally, particles with a positive charge 
have been seen to be endocytosed more rapidly since they 
may be expected to bind to the negatively charged cell 
surface [20]. However, there are reports of a higher uptake 
of negatively charged particles, e.g., in HEK cells [21], and 
neutrally charged particles have demonstrated much lower 
opsonization rates than charged particles [22, 23].  
 
In this study we have assessed engineered mesoporous 
silica nanostructures for their suitability as potential drug 
delivery vehicles. We have evaluated the nanoparticles in 
terms of their physical and nanostructural attributes, 
interaction with model-drug molecules, and time-
dependent behaviour in conditions that mimic those of 
the human body. 
2. Materials and Methods 
 
2.1 Synthesis of MSNPs  
 
2.1.1 Hexagonal-symmetry (HMSNP) 
The synthesis was performed using the method from 
reference [24]. The method can be briefly described as 
follows: 100 mg Cetyl trimethylammonium 
bromide (CTAB, Aldrich; 99 %) was dissolved in 48 mL 
ddH2O and 350µL of 2M NaOH and vigorously stirred in 
a round-bottom flask at 80 °C. After the temperature was 
stabilized, 500 µL Tetraethyl orthosilicate (TEOS, Aldrich) 
was added. After a further two hours incubation, the 
nanoparticles were collected by centrifugation and 
washed twice with methanol. The CTAB surfactant was 
removed by overnight reflux in acidic methanol (20 mL 
methanol, 1 mL 37 % hydrochloric acid) at 80 °C.
 
2.1.2 Blackberry-like MSNPs (BMSNP) 
 
The particles were synthesized using a modified version 
of the method from reference [25]. In a typical synthesis, 
100 mg CTAB was dissolved in 30 mL ddH2O and 
incubated at 60 °C. After the temperature was stabilized, 
9.6 mL octane (Sigma-Aldrich), 81.34 µL styrene 
solution (5000 µg/mL in methanol solution; Sigma), 22 
mg L-lysine (SAFC), 1.07 mL TEOS and 34.23 mg AIBA 
(Sigma) were added. The reaction was incubated and 
stirred for a further three hours under N2 at 60 °C. The 
reaction was then cooled to room temperature and 
stirred overnight.  
 
Nanoparticles were collected by centrifugation and 
washed three times with absolute ethanol. To remove the 
organic templates, the particles were refluxed with 
toluene in a Soxhlet extractor at 150 °C for 48 hours. 
 
2.1.3 Chrysanthemum-like MSNPs (CMSNP) 
 
CMSNPs were prepared using the method from 
reference [26]. The method can be described briefly as 
follows: 8 mL ddH2O was mixed with 40 mL diethyl 
ether (Sigma), and 1 mL 28 % ammonia solution (Alfa 
Aesar) in a closed flask, which was then vigorously 
stirred at room temperature. After the mixture became 
homogeneous, 2 mL TEOS was added into the solution 
dropwise. After a further three hours of stirring, another 
2 mL TEOS was added in dropwise, and 1 g CTAB was 
added. The mixture was then stirred at room 
temperature overnight. 
 
The particles were washed three times with ddH2O and 
dried in a vacuum at 60 °C overnight. To remove the 
template, the particles were fired at 550 °C for six hours. 
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2.1.4 Amorphous silica 
 
The synthesis was performed using the method from 
reference [27]. 36.8 mL absolute ethanol was mixed with 
20.25 mL ddH2O in a flask in a sonicating water bath at 
room temperature. After 10 minutes, 0.5 mL TEOS was 
added in. The mixture was sonicated for a further 20 
minutes before the 54.44 mL 28% ammonia solution was 
added dropwise. The reaction was continued for another 
hour with sonication. 
 
The particles were collected by centrifugation and 
washed twice with ddH2O. 
 
2.2 Electron Microscopy 
 
Specimens for transmission electron microscopy (TEM) 
analysis were made by drop-casting particles onto holey 
carbon coated TEM grids (Agar). Bright field imaging and 
high-resolution (HRTEM) imaging were performed using 
a JEOL JEM-2010 microscope operating at 200 kV. A high-
angle annular dark field scanning transmission electron 
microscopy (HAADF-STEM) was conducted using a 
JEOL JEM-3000F microscope operating at 300 kV. Tilt-
series imaging was facilitated by mounting specimens in 
a specialist tomography holder (Fischione Instruments 
Inc.). Specimens were also analysed with scanning 
electron microscopy (SEM), with backscattered electron 
images being obtained from a JEOL JSM-840A instrument 
operating at a primary energy of 10 kV. An analysis of the 
electron microscopy data was performed using the 
DigitalMicrograph™ (Gatan Inc.) software. 
 
2.3 External size analysis 
 
The hydrodynamic particle size distributions were 
measured using a Disc Centrifuge (DC 18000; CPS 
instrument). A sucrose gradient was prepared, and the 
machine operated at 24,000 rpm. PVC calibration 
standard (0.377 µm) was applied. All the particles were 
measured in triplicate. The main peak, standard deviation 
and polydispersity index were collected. 
 




The surface area was evaluated with nitrogen adsorption-
desorption isotherm measurements on a Gemini VI 
(Micromeritics Corp. Atlanta, GA) surface analyser at -
196 oC. The nanoparticles were degassed at 50 °C 
overnight before analysis. The surface areas were 
calculated with Brunauer-Emmett-Teller (BET) [28] 






Where SABET is the BET surface area (m2/g); CSA is the 
analysis gas molecular cross-sectional area (0.162 nm2 for 
N2); NA is the Avogadro constant 6.023 × 1023;  S is the 




The pore volume and pore size distributions were 
obtained from an adsorption branch by using the Barrett, 
Joyner and Halenda (BJH) method [29]. 
 
rp = ����������� �
 + 3.54 ×( ����	� ����
)0.333 
 
Where rp is pore radius (Å). 
 
2.4.3 Calculated surface characteristics 
 
The outer surface area of the nanoparticles was calculated 
using the following formula: 
 
The outer surface area of one MSNP: 
 
Ssingle = πd2 
 
Where ‘d’ is the outer dimension of one MSNP. 
 
Total outer surface area of one MSNP: 
 
Souter = N·Ssingle 
 
Where ‘N’ is the number of nanoparticles. 
 
In every one gram of MSNP, set N = 1 g/msingle where 
msingle is the mass of one HMSNP. 
msingle = ρ·Vsingle, where ‘ρ’ is the equivalent density of 
mesoporous silica material and Vsingle is the overall 
volume of one MSNP, which is equal to 1/6 πd3 
 








Here ρsilica is the density of the silica; Vpores is the volume 
of the pores in MSNPs. 
Therefore: 
 
Souter = N·Ssingle = ���������
 · Ssingle 
= ��
ρ��������






 · πd2 
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Here, ‘d’ is measured using TEM and the values for Vpores 
are determined experimentally (section 2.3), while the 
other parameters are constants. (Surface area of pores, 
Spores = SBET - Souter) 
 
2.5 MSNP Adsorption/ Desorption of cargo   
 
The fluorescent dyes calcein (Ex. 495, Em. 515 nm) and 
Rhodamine B were used as model drugs to examine the 
loading and unloading of the nanoparticles. The MSNPs 
were resuspended in water.  Calcein was suspended in 
dimethylformamide (DMF) and added to the 
nanoparticle suspension at a final concentration of 3 
mg/mL.  The particles were incubated at room 
temperature, with constant stirring for 24 hours. The 
particles were collected by centrifugation and washed 
with methanol: H2O (1:1 v/v) three times. 
 
To determine the dye release, the MSNPs were re-
suspended in PBS at a concentration of 10 mg/mL. 
Calcein, released from uncoated or eight layers of 
PAH/PSS coated HMSNPs, was tracked using an Infinite 
200 plate reader (Tecan) over 60 hours at 10 minute 
intervals (see also section 2.6). The filter sets used for 
Calcein were Excitation 465(35), Emission 510(10), and for 
Rhodamine B Excitation 544(25), and Emission 612(10). 
 
2.6 MSNPs capped with polyelectrolyte 
 
The MSNPs were capped with a repeating sandwich layer 
of the polycation, poly-allylamine hydrochloride (PAH; 
Sigma-Aldrich) and the polyanion, poly-sodium 4-styrene 
sulfonate (PSS; Sigma). 200 mg MSNP was added to 20 
mL Capping Buffer (20 mM Tris, 20 mM NaCl, pH 8.5) 
and resuspended by sonication for three minutes. PAH or 
PSS was resuspended in a Capping Buffer at 20mg/mL.  
0.5 mL PAH solution was added to the MSNP suspension 
and incubated and stirred for 30 minutes at room 
temperature. The PAH capped particles were then 
collected by centrifugation and washed three times with 
ddH2O. Alternate PAH/PSS layers were added to the 
particles, until the desired number of layers had been 
achieved. 
 
2.7 Degradation of MSNPs 
 
The MSNPs were suspended in a physiological buffer; 
Dulbecco’s Phosphate Buffered Saline without Calcium 
chloride or Magnesium chloride (8 g Sodium Chloride, 
0.2 g Potassium Phosphate, monobasic, 1.15 g Sodium 
Phosphate, dibasic, and 0.2 g Potassium Chloride per 
litre; Sigma). The particles were sonicated for 15 minutes 
in a sonicating water bath to ensure their complete 
resuspension. The MSNPs were subsequently incubated 
at 37 °C and samples were periodically removed for TEM 
imaging. 
3. Results and Discussion 
 
3.1 Size and morphology of nanoparticles  
 
The nanoparticle’s morphology and external diameter, in 
addition to their surface area and pore architecture are all 
key parameters in determining the utility of synthesized 
nanoparticles for in vivo nanoparticulate drug delivery 
applications. Mesoporous silica nanoparticles are 
attractive candidates for drug delivery and, consequently, 
our current study compares three different particle 
morphologies all synthesized with an aspect ratio of 




Figure 1. Characterization of three families of synthesized 
mesoporous silica nanoparticles via electron microscopy. (a) and 
(b) show scanning electron and transmission electron 
micrographs of HMSNPs, respectively  (c) and (d) show SEM 
and TEM micrographs of BMSNPs, and (e) and (f) show SEM 
and TEM micrographs of CMSNPs.  In each case, the SEM 
micrograph shows an aggregate of particles, while the higher-
resolution TEM imaging reveals further information regarding 
the extent and internal structure of individual nanoparticles. 
 
Figure 1 shows the general morphology of each set of 
nanoparticles described in this article, characterized with
both SEM and TEM.  This combination of techniques 
enables us to visualize individual nanoparticles and 
associated particle-aggregate morphologies, in addition 
to the detailed internal structure of particles. Figure 1a 
and 1b show SEM and TEM micrographs of Hexagonal- 
 





Particle Size (nm) Pore size (nm) 
TEM CPS TEM BJH 
Size 
No. 
measured Size PDI Size 
No. meas-
ured Adsorption Desorption 
HMSNP 105.66 ± 23.11 431 98.77 1.32 2.13±0.21 544 2.87 2.89 
BMSNP 63.82 ± 7.39 47 57.47 1.90 Not measurable 7.30 6.09 
CMSNP 754.75 ± 313.69 7 998.81 3.20 2.03±1.22 83 3.28 3.22 
Table 1. Summary showing the numerical results of TEM, CPS, BET and BJH measurements 
 
symmetry mesoporous silica nanoparticles (HMSNP) 
and their aggregates, respectively. Similarly, Figures 1c 
and 1d show the morphology of Blackberry-like 
mesoporous silica nanoparticles (BMSNP) and Figures 
1e and 1f show Chrysanthemum-like mesoporous silica 
nanoparticles (CMSNP). To accurately determine their 
size, TEM images of nanoparticles were analysed, and 
compared to measurements from a disc centrifuge 
analysis. Table 1 shows these measurements under the 
heading ‘particle size’ and, overall, a good agreement 
between the two methodologies is observed. The 
CMSNP particles are just outside the expected 
maximum cut-off size of 600 nm (Figure 1e & 1f, Table 
1) for fenestrated vasculature. This large external 
nanoparticle diameter would also reduce cellular 
uptake; probably being limited to micropinocytosis.  
 
The BMSNPs are approximately (63 ± 7) nm (Figure 1c & 
1d, Table 1) which is an appropriate size for cell uptake, 
but could possibly be lost via the kidneys.  The HMSNPs 
are approximately (105 ± 23) nm in diameter (Figure 1a & 
1b, Table 1) which would enable them to pass into the 
cells, but also avoid being lost through hepatic filtration.  
 
3.2 Surface characteristics 
 
Nanoparticle pore size was also assessed using a 
combination of high-resolution TEM imaging and BJH 
Pore Size and Volume Analysis. Image analysis was 
performed on TEM micrographs using the Gatan Digital 
Micrograph software in order to accurately determine 
the nanopore size.  Images, such as those of the HMSNPs 
shown in Figure 2a, were selected for the pore size 
measurements.  Here, the TEM objective lens defocus was 
selected to minimize Fresnel contrast near the pore edges, 
and, once this and the background contrast level are 
taken into account, the full width at the half-maximum 
pore size was measured by hand with a line profiling 
process as shown in Figure 2. The measured pore sizes 
are shown in Table 1 and correspond to approximately 2 
nm for both CMSNPs and HMSNPs (Table 1). In the case 
of the well-ordered HMSNPs, the pore diameter was 
determined from images of two generic nanoparticle 
orientations; a high-symmetry 6-fold axis orientated 
parallel to the electron beam, as shown in Figure 2a, and 
for pores orientated perpendicular to the beam.  In this 
second case, the nanoparticles were tilted approximately 
90 degrees from the orientation shown in Figure 2a and 
show a series of pore channels.  This commonly observed 
orientation gives access to much higher counting statistics 
and is discussed further in Figure 4. 
 
 
Figure 2. The external diameter and pore diameter of each of the 
nanoparticle morphologies was determined from the TEM 
micrographs. Figure 2 shows an example of the process. HRTEM 
images, such as figure 2(a), reveal the pore structure.  Individual 
pores (see inset of figure 2(a) are line profiled using the Digital 
Micrograph software. Figure 2(b) shows the resulting line 
profile, where the full width at half-maximum is extracted from 
the image intensity.   
 
The pore diameter was found to be (2.07 ± 0.28) nm (n=65) 
for those particles imaged normal to the beam and the 
channels (2.02 ± 0.22) nm in diameter (n=316). This 
indicates that the HMSNPs are permeated by ordered 
arrays of channels of consistent diameter (see also Figures 
3 & 4). The ill-defined edges of the pores of the BMSNPs 
made it impossible to assess their size using TEM. 
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BJH analysis was employed to determine the pore area 
and specific pore volume using adsorption and 
desorption techniques. This technique characterizes pore 
size distribution independent of the external area due to 
the particle size of the sample. Pore size analysis using 
BJH gave results comparable to those obtained using
TEM, i.e., 2.8 nm for HMSNPs and approximately 3.2 nm 
for CMSNPs (Table 1; isotherm plots are shown as 
supplemental data). A comparatively larger pore size of 
7.3 nm was shown for BMSNPs. 
 
BET Surface Area Analysis provides specific nanoparticle 
surface area evaluation via nitrogen multilayer 
adsorption, measured as a function of relative pressure. 
Here, it was determined that nanoparticle surface area 
would increase in the order BMSNP < CMSNP < HMSNP 
(Table 2). A comparison of the surface areas for the 
CMSNPs and HMSNPs relative to their external diameter 
indicates a much greater internal surface area for 
HMSNPs. This ranking follows that of the degree of 
nanopore structural ordering observed in the TEM 
imaging and suggests that the primary factor determining 
the overall surface area is the efficiency of pore packing in 
the particle interior.  
 
The total surface area for HMSNPs was shown to be (1110 
± 1.73) m2/g (Table 2). From experimental data, we have 
calculated the outer surface area of these particles to be 
(80.70) m2/g, and the pore surface area to be 92.70 % of the 
total (Table 2). The data correlate well with those of Hata
et al. [30] for similar nanoparticles C16FSM, where (SBET = 
1015) m2/g, (Sout = 82) m2/g, (Spore/SBET = 0.92). The total 
surface area for BMSNPs was shown to be (303 ±  0.998) 
m2/g (Table 2). From experimental data, we have 
calculated the outer surface area of these particles to be 











HMSNP 80.70 92.70 -31.08 1110.89 ± 1.73
BMSNP 90.97 69.98 1.13 303.02 ± 1.00 
CMSNP n/a n/a -18.00 934.18 ± 1.03 
 
Table 2. Calculated surface area and pore volume of the MSNPs. 
Souter= outer surface area,   SBET = BET surface area, Spore = pore 
surface area (SBET-Souter)  
 
Since the silica chemistry of the outer surface is expected 
to be the same as that of the inner pore surface, it is 
important to note that there would not be any preferential 
adsorption of the drug molecule onto external surfaces or 
on the pore surface. As such, the relative surface areas of 
the external surface and pore surfaces will most likely be 
reflected in the distribution of adsorbed molecules, 
assuming that the molecules are of an appropriate size to 
be localized in the pores.  
Since the morphologically different particles were 
prepared by different methods, the surface chemistry may 
differ, and so the zeta potential was measured. The zeta 
potential of HMSNPs, BMSNPs, CMSNPs and SNP were (-
31.08 ± 0.873), (1.13 ± 0.353), (-18.00 ± 0.624), and (-47.93 ± 
2.108), respectively, at physiological pH. It is generally 
accepted that mesoporous silica is negatively charged 
above the isoelectric point (pH 2-3; [31]). The positive 
charge of the BMSNPs may be due to some polystyrene 
templates being incompletely removed after the toluene 
extraction step. The synthesis is based on the method 
developed by Nandiyanto et al. [25], who do not comment 
on the zeta potential of their particles after synthesis. 
 
3.6 Microscopy study of the pore mesostructure 
Since the BET data showed that the HMSNPs have a very 
high surface area (Table 2), while having a lower outer 
surface area than BMSNPs (Table 2), high-resolution 
transmission electron microscopy (HRTEM) and high-
angle annular dark field scanning transmission electron 
microscopy (HAADF-STEM) were used to further 
investigate the details of the porous mesostructure of the 
HMSNPs. Figure 3 shows a comparison between two 
HMSNPs in different orientations along with a group of 
typical BMSNPs; CMSNPs are too large to be usefully 
imaged by TEM.  
 
Firstly, Figure 3a shows a HMSNP viewed along the high 
symmetry axis. The Fast Fourier Transform (FFT) of the 
high-resolution image in Figure 3b reveals an ordered set 
of reflections in reciprocal space with an overall six-fold 
symmetry. The sharpness of the spots indicates that there is 
little variance of the pore size throughout the particle, as 
confirmed by our statistical measurements on many HRTEM 
images reported in Table 1. The presence of a single set of six 
spots in the FFT suggests that the pores remain in an ordered 
structure throughout the volume of the particle and are not 
internally divided into separate sub-domains of pores. 
Figure 3c shows another HMSNP orientated with pores 
running approximately normal to the direction of the 
electron beam. The corresponding FFT in Figure 3d with 
two-fold symmetry confirms the ordered pore 
mesostructure with a single dominant direction through 
the particle. The particle morphology is observed to be 
non-spherical and elongated along the direction of the pore 
channels. The BMSNPs shown in Figure 3e, however, do 
not show a regular array of pores in HRTEM imaging. The 
FFT in Figure 3f does not display any periodicity, 
suggesting the absence of an ordered pore mesostructure. 
The image contrast of these particles in HRTEM consists of 
a series of bright and dark patches, corresponding to 
regions of differing projected density. These observations 
lead to the conclusion that pores in the BMSNPs consist of 
open surface pores and randomly distributed internal 
voids as opposed to the highly structured network of pore 
channels running though the HMSNPs. Continuous pore 
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channels running through the interior of HMSNPs would 
account for the high surface area of these particles and also 
their desirable degradation characteristics. Here liquid 
would be able to penetrate the interior of the particle, 
allowing structural degradation to occur simultaneously 




Figure 3. Comparison of HMSNP and BMSNP via HRTEM and 
corresponding FFTs.  (a) HRTEM image and (b) associated FFT 
of an HMSNP orientated with a high-symmetry pore axis 
aligned parallel with the electron beam.  (c) HRTEM image and 
(d) associated FFT of a HMSNP aligned with pores orientated 
normal to the direction of the electron beam (e) HRTEM image of 
a group of BMSNP and (f) associated FFT 
 
In order to confirm this interpretation, HAADF-STEM 
imaging of HMSNPs was conducted over an extended tilt 
range (90°) acquiring images for every 2° of tilt.  Figure 4 
shows a selection of four images from the series, where the 
three labelled particles may be tracked throughout the series 
with the pores (shown here with dark image contrast) 
visible. Due to the high tilts employed, some particles start to 
overlap in the projection by the end of the series. Particle 1 
begins near to a high symmetry orientation and rotates such 
that the pore channels are visible lengthways in Figures 4c 
& d.  Particles 2 and 3 begin in an intermediate orientation 
between the images showing a six-fold and two-fold pore 
projection.  In Figures 4c and 4d these particles have tilted 
to show the continuous pore structure. The HAADF-STEM 
imaging technique is incoherent and gives an image 
contrast solely dependent on the projected mass-thickness. 
As such, it is ideal for visualizing the structure of the 
internal pore channels and confirms that individual pores 
run through the length of the particle and are arranged in a 
quasi-hexagonal structure. 
 
3.3 Nanoparticle loading with a model drug. 
 
Next, we examined the loading of the various 
nanoparticles with two fluorescent model drugs.  Calcein 
is a negatively charged fluorophore, while Rhodamine B 
is positively charged at neutral pH [32]. Both drugs are 
known to self-quench; calcein, even at low concentrations 
[33], while Rhodamine B shows quenching at higher 
concentrations [34].  
 
 
Figure 4. HAADF-STEM images of a group of HMSNPs, taken 
from a tilt series acquisition.  (a) Image obtained from the initial 
axial specimen orientation, (b) specimen tilt 20 degrees, (c) 
specimen tilt 40 degrees and (d) specimen tilt 70 degrees. 
 
To test the intramolecular quenching of calcein we 
assessed its fluorescence over the range 0-5mg/ml. 
Between 0 and 0.02 mg/ml the increase in the fluorescence 
signal can be seen to be linear (Figure 5a insert). After 
approximately 0.1 mg/ml the signal reaches a maximum 
due to quenching and no longer increases with increasing 
concentration (Figure 5a). Between 1 mg/ml and 5 mg/ml, 
the fluorescence signal decreases (data not shown). The 
fluorescence of Rhodamine B shows the same pattern 
(Figure 5b). 
 
The particles were then incubated with the model drugs 
to assess their ability to carry cargo. As a control we 
included a spherical silica nanoparticle (63.56 ± 14.83) nm 
(72 measured) which would not be expected to hold the 
drug, and can be seen to have behaved accordingly 
(Figure 6a & 6c).  
 
Furthermore, the negatively charged SiO- groups enable 
chemical groups to be adsorbed on to the MSNPs since the 
silanol groups deprotonate at neutral pH, permitting 
electrostatic interactions with positively charged molecules 
[35]. For calcein, the BMSNPs and CMSNPs could be seen 
to have a greater loading capacity than the HMSNPs (Fig. 
6a), despite the determined surface area (Table 2). 
However, since the calcein is a negatively charged 
molecule, it follows that the calcein would most likely be 
attracted to the silica with the least negative charge, i.e., 
BMSNPs (Table 2). Nandiyanto et al. [25] did not measure 
the zeta potential of the BMSNPs, but it is possible that the 
particles retain some polystyrene after the toluene 
extraction, thereby giving areas of positive charge. Despite 
this, the loading uptake is still relatively low.
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Figure 5. Concentration dependence of (a) calcein and (b) rhodamine B fluorescence showing molecular quenching of the dyes.  
Insets show detail of a low concentration of dye. 
 
 
Figure 6. Loading and unloading characteristics of the various MSNPs with the model drug calcein (a & b) and rhodamine B (c & d).  
(a) Adsorption of calcein by the MSNPs after incubation with 3 mg/ ml calcein, determined by subtraction from the initial concentration  
(b) adsorption of Rhodamine B by the MSNPs after incubation with 3 mg/ml Rhodamine B (c) Release profiles of the calcein from the 
nanoparticles after resuspension in water (d) Release profiles of the Rhodamine B from the nanoparticles after resuspension in water. 
 
HMSNP BMSNP CMSNP Control 
Total loaded Calcein (µg) 1136.48 1950.80 1697.26 13.24 
Release Calcein in 65 hours (µg) 316.24 582.91 931.91 0.72 
Immobilised Calcein  (µg) 820.23 1367.89 765.35 12.53 
 
HMSNP BMSNP CMSNP Control 
Total loaded Rhodamine B (µg) 5679.00 4815.00 4725.00 14.19 
Release Rhodamine B in 65 hours (µg) 1674.00 1297.23 1565.02 0.06 
Immobilised Rhodamine B (µg) 4005.00 3517.77 3159.98 14.13 
Table 3. Absolute amounts of the model drugs calcein and Rhodamine B were calculated from both uptake and release profiles
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Figure 7. Degradation of HMSNPs coated with eight layers of PAH/PSS (a) Before degradation clearly showing a thick polyelectrolyte 
layer on the surface (b) After eight days incubation in a physiological buffer at 37 °C the polyelectrolyte layer is no longer present and 
the pores are indistinct. (c) Calcein release profile of coated and uncoated HMSNPs. 
 
For negatively charged drugs, the adsorption profile could 
likely be improved by modifying the silica surface; e.g., 
incorporating a cationic amine-modified silane 3-[2-(2-
aminoethylamino) ethylamino] propyltrimethoxy-silane 
(AEPTMS) was shown to improve the uptake of negatively 
charged drugs [36]. Conversely, HMSNPs with the lowest 
zeta potential (Table 2) and the highest surface area 
adsorbed the greatest amount of the negatively charged 
Rhodamine B (Figure 6c). Moreover, loading rates are 
higher for the three MSNPs with Rhodamine B than with 
calcein. The total loading and unloading for the different 
nanoparticles was determined with both calcein and 
Rhodamine B (Table 3). Both the BMSNPs and CMSNPs 
were seen to unload calcein rapidly, however, the release 
of calcein from the HMSNPs can be seen to give a more 
steady release over a longer time period (Figure 6b). The 
release profiles for Rhodamine B were similar for the 
different MSNP architectures.  However, the amount of 
both calcein and Rhodamine B released from HMSNPs and 
BMSNPs were very similar, while CMSNPs released a 
higher percentage over the incubation period (Table 3). 
 
It is worth noting that the solvents used for the 
adsorption of the drug can greatly affect the uptake, and 
properties such as the solubility parameter, the dispersion 
solubility parameter, the orientation solubility parameter 
and the proton-acceptor solubility parameter should be 
taken into consideration [30]. Studies have shown, for 
example, that taxol is adsorbed into mesopores in 
dichloromethane or toluene solution, whereas taxol was 
not adsorbed in methanol or acetone solution [30]. We 
have observed similar differences in the adsorption of the 
chemotherapeutic LY294002 (data not shown). Another 
factor which affects the loading and unloading of cargo is 
the relative dimensions of the pore and the drug 
molecule. It has been found that when the pore diameter 
and drug molecule are approximately the same size there 
is a sustained release due to the confinement effect. When 
the pore size is much larger than the drug molecule then 
the cargo can be released at a relatively higher rate [37]. 
The Stokes-Einstein radius of calcein is estimated as 0.6 
nm, and, assuming hydration with a uniform layer of 
water molecules (0.2 nm), results in a hydrated calcein 
radius of 0.8 nm [38].  
3.4 Nanoparticle coating with polyelectrolyte  
for delayed cargo release 
One particularly attractive property of nanoparticle drug 
delivery is the possibility of controlled release. The 
purpose of this is to maintain drug concentrations in the 
blood or in target tissues at an optimal amount for as long 
as possible (Langer & Wise, 1984). To investigate the 
possibility of delayed release, we coated the HMSNP 
nanoparticles with a thin polyelectrolyte layer. The layer 
comprised (PAH/PSS)4, although the sandwich layers of 
positively and negatively charged electrolyte can be 
continually built up. Since the silica is negatively charged, 
the first-layer coating was the positively charged 
polycation PAH, followed by the negatively charged PSS. 
The coating with each layer was followed by zeta 
potential measurements (data not shown). 
 
To determine that the polyelectrolyte layer could be 
degraded after incubation in a physiological buffer, 
HMSNPs were coated with eight layers of polyelectrolyte. 
Samples were incubated at physiological pH 7.4 and at 
pH 6.5 which could be expected in the centre of a tumour. 
Samples were removed over 48 hours and examined 
using TEM. The thickness of the coating was seen to 
decrease over time and also to decrease more when 
incubated in a slightly acidic environment (Table 4).  
 
A further experiment showed that incubating HMSNPs 
coated with eight layers of PAH/PSS (28.65  ± 3.77 nm; 
Fig. 7a) in an aqueous environment at 37 °C for eight days 
could completely diminish the polyelectrolyte ring from 
the surface (Figure 7b). 
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  0hrs 24hrs, pH 7.4 24hrs, pH 6.5 48hrs, pH 7.4 48hrs, pH 6.5 
Average thickness 24.45 20.12 19.21 18.08 13.18 
Standard Deviation 2.35 2.38 2.58 2.2 3.25 
Number measured 40 39 34 56 12 
Table 4. Thickness of polyelectrolyte coating after incubation in a physiological buffer at either pH 6.5 or pH 7.4, as determined from 
TEM images.  
 
Figure 8. CMSNPs were incubated in a physiological buffer and samples removed over a period of time to determine the degradation 
characteristics. The figure shows TEM images (a) before incubation, (b) after incubation for 32 days in a physiological buffer, and (c) 
after 173 days in a physiological buffer - here the particles are highly agglomerated. Higher magnification insets illustrate the effect on 
the pore structure. 
 
To study the release of cargo from coated nanoparticles, 
HMSNPs were loaded with calcein followed by eight 
PAH/PSS polyelectrolyte sandwich layers. The release of 
the calcein from the particles in an aqueous suspension 
was then followed spectrophotometrically. It can be 
seen that initially there is a much slower release of 
calcein when compared to the uncoated control. After 
approximately 75 hours it can be seen that the kinetics 
of the release profile are altered (Figure 7c). This is 
consistent with the dissolution of the polyelectrolyte, 
followed by a more rapid release of the calcein from the 
mesoporous silica. Therefore, a simple time-controlled 
release system can be easily constructed. It can be 
envisaged that a more sophisticated coating could be 
constructed using materials suitable for an 
environmentally triggered release. 
 
3.5 Silica nanoparticles degrade under  
physiological conditions 
 
In addition to the cargo-carrying properties of the 
nanoparticles, it is necessary to consider the problem of 
nanoparticle accumulation within an organism after 
drug delivery. This therefore requires that nanoparticles 
be degradable in biological systems. The inherent 
dissolution characteristics of silica within aqueous 
systems make it an ideal candidate for in vivo drug 
delivery [39]. The solubility of amorphous silica in 
water at a neutral pH has been evaluated as being from 
70 to more than 250 ppm at 25 °C [40]. The variation can  
 
be due to electrolyte concentration, differences in 
particle size, the state of internal hydration, or 
impurities either in the silica itself or adsorbed on its 
surface during the treatment [41]. It would be expected, 
however, that the large surface area of mesoporous 
silica nanoparticles would increase the degradability of 
the silica due to the greater interfacial contact with 
water. 
 
We therefore investigated the degradation 
characteristics of the different morphologies of the 
MSNPs. All samples were incubated in phosphate 
buffered saline; a water-based salt solution containing 
sodium chloride, sodium phosphate, potassium chloride 
and potassium phosphate. The osmolarity and ion 
concentrations of the solution are designed to 
approximate those of the human body. The samples 
were kept at 37 °C, again to simulate physiological 
conditions. 
 
CMSNPs have a high surface area (934 m2/g) and pores of 
2-3 nm (Table 2). After 32 days of incubation it can be 
seen that the mesostructure of the ‘petals’ is very different 
and the discrete pores are replaced with an open lacy 
structure (Figure 8). After 173 days it can be seen from 
TEM images that there is significant inter-particle 
conglutination, to the point where individual particles 
can no longer be discerned. In comparison, the BMSNPs 
appear to be relatively unaffected by incubation in the 
physiological medium. The morphology appears  
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unchanged (Figure 9a-c), and the decrease in the external 
diameter is not significant over 32 days (Figure 9d). 
 
The external diameter of HMSNPs decreases in size to 
(71.4 ± 12.2) % with the curve fit  over 
the course of 180 days of incubation (Figure 10g). 
However, it is apparent that the dissolution of the 
HMSNPs has taken place not only from the outer 
surface, but also internally due to the liquid present 
within the pores. Simultaneous degradation from the 
outer and inner surfaces was also seen by Yamada et al. 
[39]. As a result of such degradation, a number of 
different morphologies can be clearly identified (Figure 
10d; 21 days incubation). A three-stage degradation has 
also been seen for MCM-41 silica in simulated body 
fluids, with a fast bulk degradation within two hours 
followed by two later stages over a number of days [42]. 
 
An increase in the specific surface area of nanoparticles is 
quite effective in increasing the degradability of colloidal 
silica nanoparticles because of the greater contact with 
water at the interfaces. This fits with our experimental 
data, where BMSNPs which have the lowest surface are 
(Table 2) the least degraded, and the CMSNPs and 
HMSNPs which have an approximately three-fold greater 
surface area show significantly altered morphology and 
reduction in their external diameter. Furthermore, porous 
nanoparticles, such as those used in this study, would be 
more susceptible to dissolution since it is known that the 
solubility of any solid phase is higher when the surface is 
convex (spherical particles) and lower when it is concave 
(porous particles) [43]. In fact, the solubility depends on 
the radius of the curvature of the surface: the smaller the 
absolute value of the radius, the greater the effect on the 
solubility. In our experimental set-up, the supernatant 
was not removed over the course of the experiment. This 
may lead to the redeposition of the dissolved silica [44]. 
This dynamic equilibrium between silicate dissolution 
and re-deposition during the silica degradation process 
will be influenced by factors such as temperature, pH, 






Figure 9. BMSNPs were incubated in a physiological buffer and samples removed over a period of time to determine the degradation 
characteristics. Figures 9a-9c show TEM images (a) before incubation, after (b) six days, (c) after 32 days in a physiological buffer. In (d) 
we see the external diameter of nanoparticles determined from TEM images. 
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Figure 10 HMSNPs were incubated in a physiological buffer and samples removed over a period of time to determine the degradation 
characteristics. Figures (a-f) show TEM images after incubation for (a) one day, (b) six days, (c) 10 days, (d) 21 days, (e) 44 days, (f) 180, 
days, in a physiological buffer. In (g) we see the external diameter of nanoparticles determined from TEM images. 
In conclusion, we have investigated the physical and 
structural properties of a set of mesoporous silica 
nanoparticles, and examined their traits with respect to 
their use in carrying cargo for biomedical applications.  
We have shown a detailed analysis of the morphology of 
the particles with respect to their external shape and di-
ameter, pore diameter, pore structure, and surface area 
available for the adsorption of cargo. The loading and 
(g)
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unloading characteristics of both positively and nega-
tively charged model drugs were investigated. The selec-
tion of the nanoparticles will largely depend upon the 
drug to be delivered, however, for many molecules, the 
HMSNPs will provide an ideal platform; these nanoparti-
cles have a very high surface area, a pore size which is 
likely to be appropriate for containing the drug, and an 
external diameter suitable for extravasation from the 
blood stream and retention in the tumour. 
 
It has been demonstrated that a controlled release of the 
cargo is possible by modifying the surface of the particles 
with a polyelectrolyte; which also illustrates the scope for 
more sophisticated release mechanisms. Furthermore, we 
have investigated the degradation characteristics of the par-
ticles under physiological conditions; which is important for 
determining the likely fate of the nanoparticles in vivo.  
 
From the data shown, it can be appreciated that careful 
pre-selection of the nanoparticle attributes will play a 
large part in the success of the delivery of pharmaceuti-
cals to a site of interest, with controlled release, and con-




The authors would like to thank Rachel Morrison for the 
SEM images, and Begbroke Nano for access to material 
characterization equipment. HET would like to 




[1] Colilla, M., B. Gonzalez, and M. Vallet-Regi (2013) 
Mesoporous silica nanoparticles for the design of 
smart delivery nanodevices. Biomaterials Science, 
1(2): p. 114-134. 
[2] Tang, F., L. Li, and D. Chen (2012) Mesoporous Silica 
Nanoparticles: Synthesis, Biocompatibility and Drug 
Delivery. Advanced Materials, 24(12): p. 1504-1534. 
[3] Huh, S., J.W. Wiench, B.G. Trewyn, S. Song, M. 
Pruski, et al. (2003) Tuning of particle morphology 
and pore properties in mesoporous silicas with 
multiple organic functional groups. Chemical 
Communications, 18: p. 2364-2365. 
[4] Owens, D.E., and N.A. Peppas (2006) Opsonization, 
biodistribution, and pharmacokinetics of polymeric 
nanoparticles. International Journal of 
Pharmaceutics, 307(1): p. 93-102. 
[5] Diaconu, M., A. Tache, S.A.-M.V. Eremia, F. Gatea, S. 
Litescu, et al., Structural Characterization of Chitosan 
Coated Silicon Nanoparticles – A FTIR Approach. UPB 
Scientific Bulletin. 72 (3). 2010. 
[6] Muñoz, B., A. Rámila, J. Pérez-Pariente, I. Díaz, and 
Vallet-Regí, M. (2002) MCM-41 Organic Modification 
as Drug Delivery Rate Regulator. Chemistry of 
Materials, 15(2): p. 500-503. 
[7] Song, S.W., K. Hidajat, and S. Kawi (2005) 
Functionalized SBA-15 Materials as Carriers for 
Controlled Drug Delivery:  Influence of Surface 
Properties on Matrix−Drug Interactions. Langmuir, 
21(21): p. 9568-9575. 
[8] Vallet-Regi, M., A. Rámila, R.P. del Real, and J. 
Pérez-Pariente (2000) A New Property of MCM-41:  
Drug Delivery System. Chemistry of Materials, 13(2): 
p. 308-311. 
[9] Zhu, Y., J. Shi, W. Shen, H. Chen, X. Dong, et al. 
(2005) Preparation of novel hollow mesoporous silica 
spheres and their sustained-release property. 
Nanotechnology, 16(11): p. 2633. 
[10] Cavallaro, G., P. Pierro, F.S. Palumbo, F. Testa, L. 
Pasqua, et al. (2004) Drug Delivery Devices Based on 
Mesoporous Silicate. Drug Delivery, 11(1): p. 41-46. 
[11] Qu, F., G. Zhu, S. Huang, S. Li, and S. Qiu (2006) 
Effective Controlled Release of Captopril by 
Silylation of Mesoporous MCM-41. ChemPhysChem, 
7(2): p. 400-406. 
[12] Zeng, W., X.-F. Qian, Y.-B. Zhang, J. Yin, and Z.-K. 
Zhu (2005) Organic modified mesoporous MCM-41 
through solvothermal process as drug delivery 
system. Materials Research Bulletin, 40(5): p. 766-772. 
[13] Doadrio, A.L., E.M.B. Sousa, J.C. Doadrio, J. Pérez 
Pariente, I. Izquierdo-Barba, et al. (2004) Mesoporous 
SBA-15 HPLC evaluation for controlled gentamicin 
drug delivery. Journal of Controlled Release, 97(1): p. 
125-132. 
[14] Doadrio, J.C., E.M.B. Sousa, I. Izquierdo-Barba, A.L. 
Doadrio, J. Perez-Pariente, et al. (2006) Functionalization 
of mesoporous materials with long alkyl chains as a 
strategy for controlling drug delivery pattern. Journal of 
Materials Chemistry, 16(5): p. 462-466. 
[15] Vallet-Reg�́, M., J.C. Doadrio, A.L. Doadrio, I. 
Izquierdo-Barba, and J. Pérez-Pariente (2004) 
Hexagonal ordered mesoporous material as a matrix 
for the controlled release of amoxicillin. Solid State 
Ionics, 172(1–4): p. 435-439. 
[16] Brayden, D.J. (2003) Controlled release technologies 
for drug delivery. Drug Discovery Today, 8(21): p. 
976-978. 
[17] Arruebo, M., R. Fernández-Pacheco, M.R. Ibarra, and 
J. Santamaría (2007) Magnetic nanoparticles for drug 
delivery. Nano Today, 2(3): p. 22-32. 
[18] Petros, R.A., and J.M. DeSimone (2010) Strategies in 
the design of nanoparticles for therapeutic 
applications. Nat Rev Drug Discov, 9(8): p. 615-627. 
[19] Xu, A., M. Yao, G. Xu, J. Ying, W. Ma, et al. (2012) A 
physical model for the size-dependent cellular 
uptake of nanoparticles modified with cationic 
surfactants. Int J Nanomedicine, 7: p. 3547–3554. 
[20] Gratton, S.E.A., P.A. Ropp, P.D. Pohlhaus, J.C. Luft, 
V.J. Madden, et al. (2008) The effect of particle design on 
cellular internalization pathways. Proceedings of the 
National Academy of Sciences, 105(33): p. 11613-11618. 
Xinyue Huang, Neil P Young and Helen E Townley: Characterisation and Comparison 
of Mesoporous Silica Particles for Optimised Drug Delivery
13
[21] Yue, Z.-G., W. Wei, P.-P. Lv, H. Yue, L.-Y. Wang, et 
al. (2011) Surface Charge Affects Cellular Uptake and 
Intracellular Trafficking of Chitosan-Based 
Nanoparticles. Biomacromolecules, 12(7): p. 2440-
2446.  
 [22] Roser, M., D. Fischer, and T. Kissel (1998) Surface-
modified biodegradable albumin nano- and 
microspheres. II: effect of surface charges on in vitro 
phagocytosis and biodistribution in rats. European 
Journal of Pharmaceutics and Biopharmaceutics, 
46(3): p. 255-263. 
[23] Schwendener, R.A., P.A. Lagocki, and Y.E. Rahman 
(1984) The effects of charge and size on the 
interaction of unilamellar liposomes with 
macrophages. Biochimica et Biophysica Acta (BBA) - 
Biomembranes, 772(1): p. 93-101. 
[24] Hom, C., J. Lu, M. Liong, H. Luo, Z. Li, et al. (2010) 
Mesoporous Silica Nanoparticles Facilitate Delivery 
of siRNA to Shutdown Signaling Pathways in 
Mammalian Cells. Small, 6(11): p. 1185-1190. 
[25] Nandiyanto, A.B.D., S.-G. Kim, F. Iskandar, and K. 
Okuyama (2009) Synthesis of spherical mesoporous 
silica nanoparticles with nanometer-size controllable 
pores and outer diameters. Microporous and 
Mesoporous Materials, 120(3): p. 447-453. 
[26] Zhang, H., Z. Li, P. Xu, R. Wu, and Z. Jiao (2010) A 
facile two step synthesis of novel chrysanthemum-
like mesoporous silica nanoparticles for controlled 
pyrene release. Chemical Communications, 46(36): p. 
6783-6785. 
[27] Rao, K.S., K. El-Hami, T. Kodaki, K. Matsushige, and 
K. Makino (2005) A novel method for synthesis of 
silica nanoparticles. Journal of Colloid and Interface 
Science, 289(1): p. 125-131. 
[28] Brunauer, S., P.H. Emmett, and E. Teller (1938) 
Adsorption of Gases in Multimolecular Layers. 
Journal of the American Chemical Society, 60(2): p. 
309-319. 
[29] Barrett, E.P., L.G. Joyner, and P.P. Halenda (1951) 
The Determination of Pore Volume and Area 
Distributions in Porous Substances. I. Computations 
from Nitrogen Isotherms. Journal of the American 
Chemical Society, 73(1): p. 373-380. 
[30] Kosmulski, M. (2004) pH-dependent surface 
charging and points of zero charge II. Update. 
Journal of Colloid and Interface Science, 275(1): p. 
214-224. 
[31] Oh, Y.-J., T.C. Gamble, D. Leonhardt, C.-H. Chung, 
S.R.J. Brueck, et al. (2008) Monitoring FET flow 
control and wall adsorption of charged fluorescent 
dye molecules in nanochannels integrated into a 
multiple internal reflection infrared waveguide. Lab 
on a Chip, 8(2): p. 251-258. 
[32] Patel, H., C. Tscheka, and H. Heerklotz (2009) 
Characterizing vesicle leakage by fluorescence lifetime 
measurements. Soft Matter, 5(15): p. 2849-2851. 
[33] Setiawan, D., A. Kazaryan, M.A. Martoprawiro, and 
M. Filatov (2010) A first principles study of 
fluorescence quenching in rhodamine B dimers: how 
can quenching occur in dimeric species? Physical 
Chemistry Chemical Physics, 12(37): p. 11238-11244. 
[34] Tarn, D., C.E. Ashley, M. Xue, E.C. Carnes, J.I. Zink,
et al. (2013) Mesoporous Silica Nanoparticle 
Nanocarriers: Biofunctionality and Biocompatibility. 
Accounts of Chemical Research, 46(3): p. 792-801. 
[35] Liu, J., X. Jiang, C. Ashley, and C.J. Brinker (2009) 
Electrostatically Mediated Liposome Fusion and 
Lipid Exchange with a Nanoparticle-Supported 
Bilayer for Control of Surface Charge, Drug 
Containment, and Delivery. Journal of the American 
Chemical Society, 131(22): p. 7567-7569. 
[36] Hata, H., S. Saeki, T. Kimura, Y. Sugahara, and K. 
Kuroda (1999) Adsorption of Taxol into Ordered 
Mesoporous Silicas with Various Pore Diameters. 
Chemistry of Materials, 11(4): p. 1110-1119. 
[37] He, Q., and J. Shi (2011) Mesoporous silica 
nanoparticle based nano drug delivery systems: 
synthesis, controlled drug release and delivery, 
pharmacokinetics and biocompatibility. Journal of 
Materials Chemistry, 21(16): p. 5845-5855. 
[38] Edwards, D.A., M.R. Prausnitz, R. Langer, and J.C. 
Weaver (1995) Analysis of enhanced transdermal 
transport by skin electroporation. Journal of 
Controlled Release, 34(3): p. 211-221. 
[39] Yamada, H., C. Urata, Y. Aoyama, S. Osada, Y. 
Yamauchi, et al. (2012) Preparation of Colloidal 
Mesoporous Silica Nanoparticles with Different 
Diameters and Their Unique Degradation Behavior 
in Static Aqueous Systems. Chemistry of Materials, 
24(8): p. 1462-1471. 
[40] Iler, R.K. (1979) The Chemistry of Silica: Solubility, 
Polymerization, Colloid and Surface Properties and 
Biochemistry of Silica. 1979, New York: Wiley-
Interscience. 
[41] Marshall, W.L., and C.-T.A. Chen (1982) Amorphous 
silica solubilities V. Predictions of solubility behavior 
in aqueous mixed electrolyte solutions to 300°C. 
Geochimica et Cosmochimica Acta, 46(2): p. 289-291. 
[42] He, Q., J. Shi, M. Zhu, Y. Chen, and F. Chen (2010) 
The three-stage in vitro degradation behavior of 
mesoporous silica in simulated body fluid. 
Microporous and Mesoporous Materials, 131(1–3): p. 
314-320. 
[43] Finsy, R. (2004) On the critical radius in Ostwald 
ripening. Langmuir, 20(7): p. 2975-2976. 
[44] Lin, Y.-S., N. Abadeer, and C.L. Haynes (2011) 
Stability of small mesoporous silica nanoparticles in 
biological media. Chemical Communications, 47(1): 
p. 532-534. 
[45] Bass, J.D., D. Grosso, C. Boissiere, E. Belamie, T. 
Coradin, et al. (2007) Stability of Mesoporous Oxide 
and Mixed Metal Oxide Materials under Biologically 
Nanomater Nanotechnol, 2014, 4:2 | doi: 10.5772/5829014
Relevant Conditions. Chemistry of Materials, 19(17): 
p. 4349-4356. 
[46] Guthrie, C.P. and E.J. Reardon (2008) Metastability of 
MCM-41 and Al-MCM-41. The Journal of Physical 
Chemistry A, 112(15): p. 3386-3390. 
 
 
[47] Landau, M.V., S.P. Varkey, M. Herskowitz, O. Regev, 
S. Pevzner, et al. (1999) Wetting stability of Si-MCM-
41 mesoporous material in neutral, acidic and basic 
aqueous solutions. Microporous and Mesoporous 







Supplementary figure 1. Nitrogen adsorption/ desorption isotherms of HMSNPs, BMSNPs, and CMSNPs at 77k. HMSNPs and 
CMSNPs show type IV isotherms typically observed in structured mesoporous materials. BMSNPs show type V isotherms typical of 
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